1.Pasteur, L: Address to the Fraternal Association of Former Students of the École Centrale des Arts et Manufactures. Paris, May 15, 1884.
2.Sug, YS, Heller, RF, Levi, C, et al: Knowledge of stroke risk factors, warning symptoms, and treatment among an Australian urban population. Stroke 2001;32:1926–1930.
3.Schneider, AT, Pancioli, AM, Khoury, JC, et al: Trends in community knowledge of the warning signs and risk factors for stroke. JAMA 2003;289:343–346.
4.Kothari, R, Sauerbeck, L, Jauch, E, et al: Patients’ awareness of stroke signs, symptoms, and risk factors. Stroke 1997;28:1871–1875.
5.Pandian, JD, Jaison, A, Deepak, SS, et al: Public awareness of warning symptoms, risk factors, and treatment of stroke in northwest India. Stroke 2005;36:644–648.
6.Maasland, L, Koudstaal, PJ, Habbema, JD, Dippel, DW: Knowledge and understanding of disease process, risk factors and treatment modalities in patients with a recent TIA or minor ischemic stroke. Cerebrovasc Dis 2007;23:435–440.
7.Nedeltchev, K, Fischer, U, Arnold, M, et al: Low awareness of transient ischemic attacks and risk factors for stroke in a Swiss urban community. J Neurol 2007;254:179–184.
8.Anderson, BE, Rafferty, AP, Lyon-Callo, S, Fussman, C, Reeves, MJ: Knowledge of tissue plasminogen activator for acute stroke among Michigan adults. Stroke 2009;40:2564–2567.
9.Fussman, C, Rafferty, AP, Lyon-Callo, , Morgenstern, LB, Reeves, MJ: Lack of association between stroke symptom knowledge and intent to call 911. A population-based study. Stroke 2010;41:1501–1507
10.Garraway, WM, Whisnant, JP, Furlan, AJ, et al: The declining incidence of stroke. N Engl J Med 1979;300:449–452.
11.Bonita, R, Stewart, A, Beaglehole, R: International trends in stroke mortality: 1970–1985. Stroke 1990;21:989–992.
12.Sytkowski, PA, Kannel, WB, D’Agostino, RB: Changes in risk factors and the decline in mortality from cardiovascular disease. N Engl J Med 1990;322:1635–1641.
13.Lackland, DT, Roccella, E, Deutsch, AF, et al: Factors influencing the decline in stroke mortality. A Statement From the American Heart Association/American Stroke Association. Stroke 2013; published online before print Dec. 5, 2013, doi: 10.1161/01.str.0000437068.30550.cf.
14.Caplan, LR, Dyken, ML, Easton, JD: American Heart Association Family Guide to Stroke Treatment, Recovery, and Prevention. New York: Random House–Times Books, 1994.
15.Hutton, C, Caplan, LR: Striking Back at Stroke: A Doctor–Patient Journal. New York: Dana Press, 2003.
16.Caplan, LR: Stroke. New York: Demos–American Academy of Neurology, 2005.
17.Caplan, LR: Navigating the Complexities of Stroke. New York, Oxford University Press, 2013.
18.Gorelick, PB: The future of stroke prevention by risk factor modification. Handb Clin Neurol 2009;94:1261–1276.
19.Wald, NJ, Law, MR: A strategy to reduce cardiovascular disease by more than 80%. BMJ 2003;326:1419.
20.Gorelick, PB: New horizons for stroke prevention: PROGRESS and HOPE. Lancet Neurol 2002;1:149–156.
21.Lawes, CMM, Bennett, DA, Feigin, VL, Rogers, A: Blood pressure and stroke. An overview of published reviews. Stroke 2004;35:1024–1033.
22.Sacco, RL: The 2006 William Feinberg lecture. Shifting the paradigm from stroke to global vascular risk estimation. Stroke 2007;38:1980–1987.
23.Wolf, P, Dyken, M, Barnett, HJM, et al: Risk factors in stroke. Stroke 1984;15:1105–1111.
24.Shaper, AG, Phillips, AN, Pocock, SJ, et al: Risk factors for stroke in middle-aged British men. BMJ 1991;302:1111–1115.
25.Matchar, DB, McCrory, DC, Barnett, HJM, Feussner, JR: Medical treatment for stroke prevention. Ann Intern Med 1994;121:41–53.
26.Bronner, LL, Kanter, DS, Manson, JE: Primary prevention of stroke. N Engl J Med 1995;333:1392–1400.
27.Kalra, L, Perez, I, Melbourn, A: Stroke risk management. Change in mainstream practice. Stroke 1998;29:53–57.
28.Gorelick, PB, Sacco, RL, Smith, DB, et al: Prevention of a first stroke. A review of guidelines and a multidisciplinary consensus statement from the National Stroke Association. JAMA 1999;281:1112–1120.
29.Whisnant, JP: Stroke Populations, Cohorts, and Clinical Trials. Boston: Butterworth–Heinemann, 1993.
30.Dorndorf, W, Marx, P: Stroke Prevention. Basel: Karger, 1994.
31.Norris, JW, Hachinski, VC: Prevention of Stroke. New York: Springer, 1991.
32.Gorelick, PB, Alter, M: The Prevention of Stroke. Boca Raton, FL: Parthenon Publishing Group, 2002.
33.Go, AS, Mozaffarian, D, Roger, VL, et al: Heart disease and stroke statistics – 2014 update. A report from the American Heart Association. Circulation 2014;129:e28–e292.
34.Sobel, E, Altu, M, Davanipour, Z, et al: Stroke in the Lehigh Valley: Combined risk factors for recurrent ischemic stroke. Neurology 1989;39:669–672.
35.Davis, PH, Dambrosia, JM, Schoenberg, BS, et al: Risk factors for ischemic stroke: A prospective study in Rochester, Minnesota. Ann Neurol 1987;22:319–327.
36.Simons, LA, McCallum, J, Friedlander, Y, Simons, J: Risk factors for ischemic stroke. Dubbo study of the elderly. Stroke 1998;29:1341–1346.
37.Whisnant, JP, Wiebers, DO, O’Fallon, WM, et al: A population-based model of risk factors for ischemic stroke: Rochester, Minnesota. Neurology 1996;47:1420–1428.
38.Sacco, RL: Risk factors, outcomes, and stroke subtypes for ischemic stroke. Neurology 1997;49(suppl 4):S39–S44.
39.Goldstein, LB, Adams, R, Becker, K, et al: Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke 2001;32:280–299.
40.Johnson, P, Rosewell, M, James, MA: How good is the management of vascular risk after stroke, transient ischemic attack, or carotid endarterectomy? Cerebrovasc Dis 2007;32:156–161.
41.Romero, JR: Prevention of ischemic stroke: Overview of traditional risk factors. Curr Drug Targets 2007;8:794–801.
42.Longstreth, WT, Koepsell, T, Yerby, M, et al: Risk factors for subarachnoid hemorrhage. Stroke 1985;16:377–385.
43.Teunissen, LL, Rinkel, GJE, Algra, A, van Gijn, J: Risk factors for subarachnoid hemorrhage. A systematic review. Stroke 1996;27:544–549.
44.Qureshi, AI, Suri, MF, Yahia, AM, et al: Risk factors for subarachnoid hemorrhage. Neurosurgery 2001;49:607–612.
45.Isaksen, J, Egge, A, Waterloo, K, et al: Risk factors for aneurysmal subarachnoid haemorrhage: The Tromso study. J Neurol Neurosurg Psychiatry 2002;73:185–187.
46.Ohkuma, H, Tabata, H, Suzuki, S, Islam, S: Risk factors for aneurysmal subarachnoid hemorrhage in Aomori, Japan. Stroke 2003;34:96–100.
47.Broderick, JP: Intracerebral hemorrhage. In Gorelick, PB, Alter, M (eds): Handbook of Neuroepidemiology. New York: Marcel Dekker, 1994, pp 141–167.
48.Qureshi, AI, Suri, MA, Safdar, K, et al: Intracerebral hemorrhage in blacks: Risk factors, subtypes, and outcome. Stroke 1997;28:961–964.
49.Bateman, BT, Schumacher, HC, Bushnell, CD, et al: Intracerebral hemorrhage in pregnancy: Frequency, risk factors, and outcome. Neurology 2006;67:424–429.
50.Mitchell, P, Mitra, D, Gregson, BA, Mendelow, AD: Prevention of intracerebral haemorrhage. Curr Drug Targets 2007;8:832–838.
51.Caplan, LR: Brain embolism. In Caplan, LR, Hurst, JW, Chimowitz, M (eds): Clinical Neurocardiology. New York: Marcel Dekker, 1999, pp 35–185.
52.Caplan, LR, Manning, WJ: Brain Embolism. New York: Informa Healthcare, 2006.
53.Gorelick, PB, Caplan, LR, Hier, DB, et al: Racial differences in the distribution of anterior circulation occlusive cerebrovascular disease. Neurology 1984;34:54–59.
54.Gorelick, PB, Caplan, LR, Hier, DB, et al: Racial differences in the distribution of posterior circulation occlusive disease. Stroke 1985;16:785–790.
55.Caplan, LR: Race, sex, and occlusive cerebrovascular disease: A review. Stroke 1986;17:648–655.
56.Caplan, LR: Cerebral ischemia and infarction in blacks. Clinical, autopsy, and angiographic studies. In Gillum, RF, Gorelick, PB, Cooper, ES (eds): Stroke in Blacks. Basel: Karger, 1999, pp 7–18.
57.White, H, Boden-Albala, B, Wang, C, et al: Ischemic stroke subtype incidence among whites, blacks, and Hispanics: The Northern Manhattan Study. Circulation 2005;111:1327–1331.
58.Sacco, RL, Kargman, DE, Gu, Q, Zamanillo, MC: Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke 1995;26:14–20.
59.Lewington, S, Clarke, R, Qizilbash, N, et al: Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903–1913.
60.Kannel, WB: Current status of the epidemiology of brain infarction associated with occlusive vascular disease. Stroke 1971;2:295–318.
61.Mackay, MT, Wiznitzer, M, Benedict, SL, et al: Arterial ischemic stroke risk factors: The International Pediatric Stroke Study. Ann Neurol 2011;69:130–140.
62.Gebel, J, Broderick, J: Primary intracerebral hemorrhage and subarachnoid hemorrhage in black patients: Risk factors, diagnosis, and prognosis. In Gillum, RF, Gorelick, PB, Cooper, ES (eds): Stroke in Blacks. Basel: Karger, 1999, pp 29–35.
63.Towfighi, A, Zheng, L, Obviagele, B: Weight of the obesity epidemic. Rising stroke rates among middle-aged women in the United States. Stroke 2010;41:1371–1375.
64.Kiely, DK, Wolf, PA, Cupples, LA, et al: Family aggregation of stroke: The Framingham Study. Stroke 1993;24:1366–1371.
65.Liao, D, Myers, R, Hunt, S, et al: Family history of stroke and stroke risk. The Family Heart Study. Stroke 1997;28:1908–1912.
66.Wannamethee, SG, Shaper, AG, Ebrahim, S: History of parental death from stroke or heart trouble and the risk of stroke in middle-aged men. Stroke 1996;27:1492–1498.
67.Jousilahri, P, Rastenyte, D, Tuomilehto, J, et al: Parental history of cardiovascular disease and risk of stroke. A prospective follow-up of 14,371 middle-aged men and women in Finland. Stroke 1997;28:1361–1366.
68.Meschia, JF, Case, LD, Worrall, BB, et al: Ischemic Stroke Genetics Study Group. Family history of stroke and severity of neurologic deficit after stroke. Neurology 2006;67:1396–1402.
69.McGill, HC, Arias-Stella, J, Carbonell, LM, et al: General findings of the International Atherosclerosis Project. Lab Invest 1968;18:498–502.
70.Solberg, LA, McGarry, PA, Moosy, J, et al: Distribution of cerebral atherosclerosis by geographic location, race, and sex. Lab Invest 1968;158:604–612.
71.Freedman, DS, Khan, LK, Dietz, WH, Srinivasan, SR, Berenson, G: Relationship of obesity in childhood to coronary heart disease risk factors in adulthood: The Bogalusa Heart Study. Pediatrics 2001;108:712–718.
72.Högström, G, Nordström, A, Eriksson, M, Nordström, P: Risk factors assessed in adolescence and the later risk of stroke in men: a 33-year follow-up study. Cerebrovasc Dis 2015;39:63–71.
73.Expert Panel. Summary Report on Integrated Guidelines of Cardiovascular Health and Risk Reduction in Children and Adolescents. Bethesda, MD: US Department of Health and Human Services, National Heart, Lung and Blood Institute, NIH Publication No. 12–7486A, October 2012, pp 1–72.
74.Reis, JP, Loria, CM, Lewis, CE, et al: Association between duration of overall and abdominal obesity beginning in young adulthood and coronary artery calcification in middle age. JAMA 2013;310:280–288.
75.Kannel, WB: Blood pressure as a cardiovascular risk factor. JAMA 1996;275:1571–1576.
76.National Heart, Lung, and Blood Institute: Working Group Report on Primary Prevention of Hypertension: National High Blood Pressure Education Program. NHLBI Doc 93–2669. Bethesda, MD: National Institutes of Health, 1993.
77.Chobanian, AV, Bakris, GL, Black, HR, et al: The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 2003;289:2560–2572.
78.Go, AS, Mozaffarinan, D, Roger, VL, et al. on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics – 2013 update, a report from the American Heart Association. Circulation 2013;127:e6–e245.
79.Prospective Studies Collaboration: Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903–1913.
80.Gueyffier, F, Bulpitt, C, Boissel, J-P, et al: Antihypertensive drugs in very old people: A subgroup meta-analysis of randomized controlled trials. Lancet 1999;353:793–796.
81.Howard, G, Manolio, TA, Burke, GL, et al: Does the association of risk factors and atherosclerosis change with age? Stroke 1997;28:1693–1701.
82.Beckett, NS, Peters, R, Fletcher, AE, et al: Treatment of hypertension in patients 80 years of age or older. HYVET Study Group. N Engl J Med 2008;358:1887–1898.
83.SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1991;265:3255–3264.
84.Sutton-Tyrrell, K, Alcorn, HG, Herzog, H, et al: Morbidity, mortality, and antihypertensive treatment effects by extent of atherosclerosis in older adults with isolated systolic hypertension. Stroke 1995;26:1319–1324.
85.Davis, BR, Vogt, T, Frost, PH, et al: Risk factors for stroke and type of stroke in persons with isolated systolic hypertension. The Systolic Hypertension in the Elderly Program (SHEP) Research Group. Stroke 1998;29:1333–1340.
86.Perry, HM, Davis, BR, Price, TR, et al: Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke. Systolic Hypertension in the Elderly Program (SHEP) Cooperative Research Group. JAMA 2000;284:465–471.
87.Staessen, JA, Gasowski, J, Wang, JG, et al: Risks of untreated and treated isolated systolic hypertension in the elderly: Meta-analysis of outcome trials. Lancet 2000;355:865–872.
88.Bowman, TS, Gaziano, JM, Kase, CS, et al: Blood pressure measures and risk of total, ischemic, and hemorrhagic stroke in men. Neurology 2006;67:820–823.
89.Chobanian, AV: Isolated systolic hypertension in the elderly. N Engl J Med 2007;357:789–796.
90.Wenger, NK: Hypertension and other cardiovascular risk factors in women. Am J Hypertens 1995;8:94S–99S.
91.Rothwell, PM, Coull, AJ, Silver, LE, et al: Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet 2005;366:1773–1783.
92.Mitchell, GF, Ramachandran, SV, Keyes, MJ, et al: Pulse-pressure and risk of new-onset atrial fibrillation. JAMA 2007;297;709–715.
93.Weitzman, D, Goldbourt, U: The significance of various blood pressure indices for long-term stroke, coronary heart disease, and all-cause mortality in men. The Israeli Ischemic Heart Disease Study. Stroke 2006;37:358–363.
94.Paultre, F, Mosca, L: Association of blood pressure indices and stroke mortality in isolated systolic hypertension. Stroke 2005;36:1288–1290.
95.Vemmos, KN, Tsivgoulis, G, Spengos, K, et al: Pulse pressure in acute stroke is an independent predictor of long-term mortality. Cerebrovasc Dis 2004;18:30–36.
96.Rothwell, PM: Limitations of the usual blood pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet 2010;375:938–948.
97.Gorelick, PB: Reducing blood pressure variability to prevent stroke? Lancet Neurol 2010;9:448–449.
98.Watanabe, N, Imai, Y, Nagai, K, et al: Nocturnal blood pressure and silent cerebrovascular lesions in elderly Japanese. Stroke 1996;27:1319–1327.
99.Yamamoto, Y, Akiguchi, I, Oiwa, K, et al: Adverse effect of nighttime blood pressure on the outcome of lacunar infarct patients. Stroke 1998;29:570–576.
100.Lip, GY, Zarifis, J, Farooqi, S, et al: Ambulatory blood pressure monitoring in acute stroke. The West Birmingham Stroke Project. Stroke 1997;28:31–35.
101.Staessen, JA, Thijs, L, Fagard, R, et al: Predicting cardiovascular risk using conventional vs. ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in the Europe Trial Investigators. JAMA 1999;282:539–546.
102.Goldstein, IB, Bartzokis, G, Guthrie, D, Shapiro, D: Ambulatory blood pressure and the brain. A 5-year follow-up. Neurology 2005;64:1846–1852.
103.Tsivgoulis, G, Spengos, K, Zakopoulos, N, et al: Twenty-four-hour pulse pressure predicts long-term recurrence in acute stroke patients. J Neurol Neurosurg Psychiatry 2005;76:1360–1365.
104.Rashid, P, Leonardi-Bee, J, Bath, P: Blood pressure reduction and secondary prevention of stroke and other vascular events. A systematic review. Stroke 2003;34:2741–2749.
105.Psaty, BM, Lumley, T, Furberg, CD, et al: Health outcomes associated with various antihypertensive therapies used as first-line agents. JAMA 2003;289:2534–2544.
106.Blood Pressure Lowering Treatment Trialists’ Collaboration: Effects of different blood-pressure-lowering regimens on major cardiovascular events: Results of prospectively-designed overviews of randomized trials. Lancet 2003;362:1527–1535.
107.Hall, WD, Kong, W: Hypertension in blacks: Nonpharmacologic and pharmacologic therapy. In Saunders, E (ed): Cardiovascular Disease in Blacks. Philadelphia: FA Davis, 1991, pp 157–169.
108.Rajagopalan, S, Harrison, D: Reversing endothelial dysfunction with ACE inhibitors. A new trend? Circulation 1996;94:240–243.
109.Bosch, J, Yusuf, S, Pogue, J, et al: Use of ramipril in preventing stroke: Double blind randomized trial. HOPE Investigators. BMJ 2002;324:1–5.
110.van Gijn, J: The PROGRESS Trial: Preventing strokes by lowering blood pressure in patients with cerebral ischemia. Stroke 2002;33:319–320.
111.Hankey, GJ: Angiotensin-converting enzyme inhibitors for stroke prevention. Is there HOPE for PROGRESS after LIFE? Stroke 2003; 34:354–356.
112.Chapman, N, Huxley, R, Anderson, C, et al: Effects of a perendopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history. The PROGRESS Trial. Stroke 2004;35:116–121.
113.Iadecola, C, Gorelick, PB: Hypertension, angiotensin, and stroke: Beyond blood pressure. Stroke 2004;35:348–350.
114.Toole, FJ, Janeway, R, Choi, K, et al: Transient ischemic attacks due to atherosclerosis: A prospective study of 160 patients. Arch Neurol 1975;32:5–12.
115.Chimowitz, MI, Weiss, DG, Cohen, SL, et al: Veterans Affairs Cooperative Study Group 167. Cardiac prognosis of patients with carotid stenosis and no history of coronary artery disease. Stroke 1994;25:759–765.
116.Chimowitz, MI: Asymptomatic coronary artery disease in patients with carotid artery stenosis: Incidence, prognosis, and treatment. In Caplan, LR, Hurst, JW, Chimowitz, M (eds): Clinical Neurocardiology. New York: Marcel Dekker, 1999, pp 287–295.
117.Adams, R, Chimowitz, MI, Alpert, JS, et al. Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association. Stroke 2003;34:2310–2322.
118.DECODE Study Group, European Diabetes Epidemiology Group: Glucose tolerance and mortality: Comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 1999;354:617–621.
119.Grundy, SM, Brewer, B Jr, Cleeman, JI, et al: NHLBI/AHA Conference proceedings. Definition of metabolic syndrome. Circulation 2004;109:433–438.
120.Grundy, S, Cleeman, JI, Daniels, SR, et al: Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735–2752.
121.Bang, OY, Kim, JW, Lee, JH, et al: Association of the metabolic syndrome with intracranial atherosclerotic stroke. Neurology 2005;65:296–298.
122.Mak, KH, Ma, S, Heng, D, et al: Impact of sex, metabolic syndrome, and diabetes mellitus on cardiovascular events. Am J Cardiol 2007;100:227–233.
123.Arenillas, JF, Moro, MA, Dávalos, A: The metabolic syndrome and stroke: Potential treatment approaches. Stroke 2007;38:2196–2203.
124.Kurl, S, Laukkanen, JA, Niskanen, L, et al: Metabolic syndrome and the risk of stroke in middle-aged men. Stroke 2006;37:806–811.
125.Boden-Albala, B, Sacco, RL, Lee, H-S, et al: Metabolic syndrome and ischemic stroke risk. Northern Manhattan Study. Stroke 2008;39:30–35.
126.Li, W, Ma, D, Liu, M, et al: Association between metabolic syndrome and risk of stroke: A meta-analysis of cohort studies. Cerebrovasc Dis 2008;25:539–547.
127.Mokdad, AH, Bowman, BA, Ford, ES, et al: The continuing epidemics of obesity and diabetes in the United States. JAMA 2001;286:1195–1200.
128.Jensen, MD, Ryan, DH, Apovian, CM, et al. 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obsesity Society. J Am Coll Cardiol 2014;014;63(25_PA):doi:10.1016/j.jacc.2013.11.004.
129.Kurth, T, Gaziano, JM, Berger, K, et al: Body mass index and the risk of stroke in men. Arch Intern Med 2002;162:2557–2562.
130.Kurth, T, Gaziano, JM, Rexrode, KM, et al: Prospective study of body mass index and risk of stroke in apparently healthy women. Circulation 2005;111:1992–1998.
131.Hu, G, Tuomilehto, J, Silventoinen, K, et al: Body mass index, waist circumference, and waist–hip ratio on the risk of total and type-specific stroke. Arch Intern Med 2007;167:1420–1427.
132.Depres, J-P, Lemieux, I, Prud’homme, D: Treatment of obesity: Need to focus on high risk abdominally obese subjects. BMJ 2001;322:716–720.
133.Fox, CS, Massaro, JM, Hoffmann, U, et al: Abdominal visceral and subcutaneous adipose tissue compartments: Association with metabolic risk factors in the Framingham Heart Study. Circulation 2007;116:39–48.
134.Lear, SA, Humphries, KH, Kohli, S, et al: Visceral adipose tissue, a potential risk factor for carotid atherosclerosis. Results of the Multicultural Community Health Assessment Trial (M-CHAT). Stroke 2007;38:2422–2429.
135.Suk, SH, Sacco, RL, Boden-Albala, B, et al: Abdominal obesity and risk of ischemic stroke: The Northern Manhattan Stroke Study. Stroke 2003;34:1586–1592.
136.Ruderman, N, Chisholm, D, Pi-Sunyer, X, Schneider, S: The metabolically obese, normal weight individual revisited. Diabetes 1998;47:699–713.
137.McLaughlin, T, Allison, G, Abbasi, F, et al: Prevalence of insulin resistance and associated cardiovascular risk factors among normal weight, overweight, and obese individuals. Metabolism 2004;53:495–499.
138.Schoenberg, BS, Schoenberg, DG, Pritchard, DA, et al: Differential risk factors for completed stroke and transient ischemic attack (TIA): Study of vascular disease (hypertension, cardiac disease, peripheral vascular disease) and diabetes mellitus. Trans Am Neurol Assoc 1980;105:165–167.
139.Burchfiel, CM, Curb, D, Rodriguez, B, et al: Glucose intolerance and 22-year stroke incidence. The Honolulu Heart Program. Stroke 1994;25:951–957.
140.Jorgenson, H, Nakayama, H, Raaschou, HO, Olsen, TS: Stroke in patients with diabetes. The Copenhagen Stroke Study. Stroke 1994;25:1977–1984.
141.Karapanayiotides, TH, Piechowski-Jozwiak, B, van Melle, G, et al: Stroke patterns, etiology, and prognosis in patients with diabetes mellitus. Neurology 2004;62:1558–1562.
142.Fox, C, Coady, S, Sorlie, P, et al: Increased cardiovascular disease burden due to diabetes mellitus. The Framingham Heart Study. Circulation 2007;115:1544–1550.
143.Caplan, LR: Intracranial branch atheromatous disease: A neglected, understudied, and underused concept. Neurology 1989;39:1246–1250.
144.Caplan, LR: Diabetes and brain ischemia. Diabetes 1996;45(suppl 3):595–597.
145.Depres, J-P, Golay, A, Sjostrom, L: Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. Rimonabant in Obesity–Lipids Study Group. N Engl J Med 353:2121–2134.
146.Higa, M, Davanipour, Z: Smoking and stroke. Neuroepidemiology 1991;10:211–222.
147.Love, BB, Biller, J, Jones, MP, et al: Cigarette smoking: A risk factor for cerebral infarction in young adults. Arch Neurol 1990;47:693–698.
148.Whisnant, JP, Homer, D, Ingall, TJ, et al: Duration of cigarette smoking is the strongest predictor of severe extracranial carotid artery atherosclerosis. Stroke 1990;21:707–714.
149.Ingall, TJ, Homer, D, Baker, HL, et al: Predictors of intracranial carotid artery atherosclerosis: Duration of cigarette smoking and hypertension are more powerful than serum lipid levels. Arch Neurol 1991;48:687–691.
150.Colditz, GA, Bonita, R, Stampfer, MJ, et al: Cigarette smoking and risk of stroke in middle-aged women. N Engl J Med 1988;318:937–941.
151.Donnan, GA, You, R, Thrift, A, McNeil, JJ: Smoking as a risk factor for stroke. Cerebrovasc Dis 1993;3:129–138.
152.Wolf, P, Kannel, WB, Verter, J: Current status of risk factors for stroke. In Barnett, HJM (ed): Neurologic Clinics, vol 1. Cerebrovascular Disease. Philadelphia: Saunders, 1983, pp 317–343.
153.Paffenbarger, R, Williams, J: Chronic disease in former college students: V. Early precursors of fatal stroke. Am J Public Health 1967;57:1290–1299.
154.Kawachi, I, Colditz, GA: Smoking cessation and decreased risk of stroke in women. JAMA 1993;269:232–236.
155.Jee, SH, Suh, I, Kim, IS, Appel, LJ: Smoking and atherosclerotic cardiovascular disease in men with low levels of serum cholesterol. JAMA 1999;282:2149–2155.
156.Kurth, T, Kase, CS, Berger, K, et al: Smoking and the risk of hemorrhagic stroke in men. Stroke 2003;34:1151–1155.
157.Collaborative Group for the Study of Stroke in Young Women: Oral contraceptives and stroke in young women: Associated risk factors. JAMA 1975;231:718–722.
158.Fust, G, Arason, GJ, Kramer, J, et al: Genetic basis of tobacco smoking: Strong association of a specific major histocompatibility complex haplotype on chromosome 6 with smoking behavior. Int Immunol 2004;16:1507–1514.
159.Arason, GJ, Kramer, J, Blasko, B, et al: Smoking and a complement gene polymorphism interact in promoting cardiovascular disease morbidity and mortality. Clin Exp Immunol 2007;149:132–138.
160.Gorelick, PB: Burden of stroke and risk factors. In Bornstein, NM (ed): Stroke. Basel: Karger, 2009, pp 9–23.
161.Tell, GS, Crouse, JR, Furberg, CD: Relation between blood lipids, lipoproteins, and cerebrovascular atherosclerosis. A review. Stroke 1988;19:423–430.
162.Kurth, T, Everett, BM, Buring, JE, et al: Lipid levels and the risk of ischemic stroke in women. Neurology 2007;68:556–562.
163.Bang, OY, Saver, JL, Liebeskind, DS, et al: Association of serum lipid indices with large artery atherosclerotic stroke. Neurology 2008;70:841–847.
164.Kannel, WB: Epidemiology of cerebrovascular disease. In Ross-Russel, RW (ed): Cerebral Arterial Disease. New York: Churchill Livingstone, 1976, pp 1–23.
165.Kagan, A, Popper, J, Rhoads, G: Factors related to stroke incidence in Hawaiian Japanese men: The Honolulu Heart Study. Stroke 1980;11:14–21.
166.Stemmerman, G, Hayashi, T, Resch, J, et al: Risk factors related to ischemic and hemorrhagic cerebrovascular disease at autopsy: The Honolulu Heart Study. Stroke 1984;15:23–28.
167.Iso, H, Jacobs, DR, Wentworth, D, et al: Serum cholesterol levels and six year mortality from stroke in 350,977 men screened for the Multiple Risk Factor Intervention Trial. N Engl J Med 1989;320:904–910.
168.Yano, K, Reed, DM, Maclean, CJ: Serum cholesterol and hemorrhagic stroke in the Honolulu Heart Program. Stroke 1989;20:1460–1465.
169.Goldstein, LB, Amarenco, P, Szarak, M, et al: SPARCL Investigators. Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study. Neurology 2008;70:2364–70.
170.Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomized placebo-controlled trial. Lancet 2002;360:7–22.
171.Hackam, DG, Austin, PC, Huang, A, et al: Statins and intracerebral hemorrhage: A retrospective cohort study. Arch Neurol 2012;69:39–45.
172.Nakamura, H, Arakawa, A, Itakura, H, et al: Primary prevention of cardiovascular events with pravastatin in Japanese (MEGA) study: A prospectively randomized controlled trial. Lancet 2006;30:1155–1163.
173.Kurth, T, Everett, BM, Buring, JE, et al: Lipid levels and the risk of ischemic stroke in women. Neurology 2007;68:556–562.
174.Tanne, D, Yaari, S, Goldbourt, U: High-density lipoprotein cholesterol and risk of ischemic stroke mortality. A 21-year follow-up of 8586 men from Israeli Ischemic Heart Disease Study. Stroke 1997;28:83–87.
175.Steinberg, D, Parthasarthy, S, Carcio, TE, et al: Beyond cholesterol: Modification of low-density lipoprotein that increases its atherogenicity. N Engl J Med 1989;320:915.
176.Scanu, A, Lawn, RM, Berg, K: Lipoprotein (a) and atherosclerosis. Ann Intern Med 1991;115:209–218.
177.Pedro-Botet, J, Senti, M, Nogues, X, et al: Lipoprotein and apolipoprotein profile in men with ischemic stroke. Role of lipoprotein (a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism. Stroke 1992;23:1556–1562.
178.Wilt, TJ, Rubins, HB, Robins, SJ, et al: Carotid atherosclerosis in men with low levels of HDL cholesterol. Stroke 1997;28:1919–1925.
179.Homer, D, Ingall, TJ, Baber, HL, et al: Serum lipids and lipoproteins are less powerful predictors of extracranial carotid artery atherosclerosis than are cigarette smoking and hypertension. Mayo Clin Proc 1991;66:259–267.
180.Taylor, FC, Huffman, M, Ebrahim, S: Statin therapy for primary prevention of cardiovascular disease. JAMA 2013;310:2451–2452.
181.Bucher, HC, Griffith, LE, Guyatt, GH: Effect of HMGCoA reductase inhibitors on stroke. A meta-analysis of randomized controlled trials. Ann Intern Med 1998;128:89–95.
182.Amarenco, P, Lavallee, P, Touboul, P-J: Stroke prevention, blood cholesterol, and statins. Lancet Neurol 2004;3:271–278.
183.SPARCL Investigators: High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006;355:549–559.
184.Paciaroni, M, Hennerici, M, Agnelli, G, Bogousslavsky, J: Statins and stroke prevention. Cerebrovasc Dis 2007;24:170–182.
185.Gorelick, PB: The status of alcohol as a risk factor for stroke. Stroke 1989;20:1607–1610.
186.Hillborn, M, Kaste, M: Alcohol intoxication: A risk factor for primary subarachnoid hemorrhage. Neurology 1982;32:706–711.
187.Kagan, A, Yano, K, Rhoads, G, et al: Alcohol and cardiovascular disease: The Hawaiian experience. Circulation 1981;64(suppl 3):27–31.
188.Bogousslausky, J, Van Melle, G, Despland, PA, Regli, F: Alcohol consumption and carotid atherosclerosis in the Lausanne stroke registry. Stroke 1990;21:715–720.
189.Palomaki, H, Kaste, M: Regular light-to-moderate intake of alcohol and the risk of ischemic stroke. Stroke 1993;24:1828–1832.
190.Kiechi, S, Willeit, J, Rungger, G, et al: Alcohol consumption and atherosclerosis: What is the relation. Prospective results from the Bruneck Study. Stroke 1998;29:900–907.
191.Gorelick, PB, Rodin, MB, Langenberg, P, et al: Is acute alcohol ingestion a risk factor for ischemic stroke? Stroke 1987;18:359–364.
192.Gorelick, PB, Rodin, MB, Langengerg, P, et al: Weekly alcohol consumption, cigarette smoking, and the risk of ischemic stroke. Neurology 1989;39:339–343.
193.Truelsen, T, Gronbaek, M, Schnohr, P, Boysen, G: Intake of beer, wine, and spirits and risk of stroke. The Copenhagen Heart Study. Stroke 1998;29:2467–2472.
194.Hertog, MG, Feskens, EJ, Hollman, PC, et al: Dietary antioxidant flavonoids and risk of coronary heart disease. Lancet 1993;342:1007–1011.
195.Frankel, EN, Kanner, J, German, JB, et al: Inhibition of oxidation of human low-density lipoproteins by phenolic substances in red wine. Lancet 1993;341:454–457.
196.Hillbom, M, Haapaniemi, H, Juvela, S, et al: Recent alcohol consumption, cigarette smoking, and cerebral infarction in young adults. Stroke 1995;26:40–45.
197.Mostofsky, E, Burgern, MR, Schlaug, G, et al: Alcohol and acute ischemic stroke onset. The Stroke Onset Study. Stroke 2010;41:1845–1849.
198.Conen, D, Tedrow, UB, Cook, NR, et al: Alcohol consumption and risk of incident atrial fibrillation in women. JAMA 2008;300:2489–2496.
199.Sull, JW, Yi, S-W, Nam, CM, Ohrr, H: Binge drinking and mortality from all causes and cerebrovascular diseases in Korean men and women. A Kangwha cohort study. Stroke 2009;40:2953–2958.
200.Sundell, L, Salomaa, V, Vartiainen, E, et al: Increased stroke risk is related to a binge drinking habit. Stroke 2008;39:3179–3184.
201.Criqui, MH: Peripheral arterial disease and subsequent cardiovascular mortality: A strong and consistent association. Circulation 1990;82:2246–2247.
202.Criqui, MH, Langer, RD, Fronek, A, et al: Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992;326:381–386.
203.Bhatt, DL, Steg, PG, Ohman, EM, et al: International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. REACH Registry Investigators. JAMA 2006;295:180–189.
204.Bogousslavsky, J, Regli, F: Cerebral infarct in apparent transient ischemic attack. Neurology 1985;35:1501–1503.
205.Awad, I, Modic, M, Little, JR, et al: Focal parenchymal lesions in transient ischemic attacks: Correlation of computed tomography and magnetic resonance imaging. Stroke 1986;17:399–403.
206.Caplan, LR: TIAs: We need to return to the question, “What is wrong with Mr Jones?” Neurology 1988;39:791–793.
207.Fazekas, F, Fazekas, G, Schmidt, R, et al: Magnetic resonance imaging correlates of transient cerebral ischemic attacks. Stroke 1996;27:607–611.
208.Inatomi, Y, Kimura, K, Yonehara, T, et al: DWI abnormalities and clinical characteristics in TIA patients. Neurology 2004;62:376–380.
209.Dennis, MS, Bamford, JM, Sandercock, PA, Warlow, CD: A comparison of risk factors and prognosis for transient ischemic attacks and minor ischemic strokes. Stroke 1989;20:1494–1499.
210.Johnston, SC, Gress, DR, Browner, WS, Sidney, S: Short-term prognosis after emergency department diagnosis of TIA. JAMA 2000;284:2901–2906.
211.Daffertshofer, M, Mielke, O, Pullwitt, A, et al: Transient ischemic attacks are more than “ministrokes.” Stroke 2004;35:2453–2458.
212.Kleindorfer, D, Pangos, P, Pancoli, A, et al: Incidence and short-term prognosis of transient ischemic attack in a population-based study. Stroke 2005;36:720–724.
213.Hill, MD, Yiannakoulias, N, Jeerakathil, T, et al: The high risk of stroke immediately after transient ischemic attack. A population-based study. Neurology 2004;62:2015–2020.
214.Rothwell, PM, Warlow, CP: Timing of TIAs preceding stroke. Time window for prevention is very short. Neurology 2005;64;817–820.
215.Amarenco, P, Lavallée, P, Labreuche, J, et al: Contemporary profile and prognosis of transient ischemic attacks in the era of urgent management. N Engl J Med, 2016;in press.
216.Touze, E, Varenne, O, Chatellier, G, et al: Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke. Stroke 2005;36:2748–2755.
217.Nguyen-Huynh, MN, Johnston, SC: Transient ischemic attack: A neurologic emergency. Curr Neurol Neurosci Rep 2005;5:13–20.
218.Ay, H, Koroshetz, WJ, Benner, T, et al: Transient ischemic attack with infarction: A unique syndrome. Ann Neurol 2005;57:679–686.
219.Albers, GW, Caplan, LR, Easton, JD, et al., for the TIA Working Group: Transient ischemic attack: proposal for a new definition. N Engl J Med 2002;347:1713–1716.
220.Easton, JD, Saver, JL, Albers, GA, et al: Definition and evaluation of transient ischemic attack: A scientific statement for healthcare professionals from the American Heart Association/American Stroke Council, Council on Cardiovascular Surgery and Anesthesia, Council on Cardiovascular Radiology and Intervention, Council on Cardiovascular Nursing, and the Interdisciplinary Council on Peripheral Vascular Disease: The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke 2009;40:2276–2293.
221.Johnston, SC, Rothwell, PM, Nguyen-Huynh, MN, et al: Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet 2007;369:283–292.
222.Merwick, A, Albers, GW, Amarenco, P, et al: Addition of brain and carotid imaging to the ABCD2 score to identify patients at early risk of stroke after transient ischemic attack: a multicenter observational study. Lancet Neurol 2010;9:1060–1069.
223.Caplan, LR: Scores of scores. JAMA Neurol 2013;70:252–253.
224.Amarenco, P, Labreuche, J, Lavallée, PC: Patients with transient ischemic attacks with ABCD2 ≤4 can have similar 90-day stroke risks as patients with transient ischemic attacks with ABCD2 ≥4. Stroke 2012;43:863–865.
225.Lou, M, Safdar, A, Edlow, JA, et al: Can ABCD score predict the need for in-hospital intervention in patients with transient ischemic attacks? Int J Emerg Med 2010;3:75–80.
226.Rothwell, PM, Giles, MF, Chandratheva, A, et al: for the Early Use of Existing Preventive Strategies for Stroke (EXPRESS) Study. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS Study): A prospective population-based sequential comparison. Lancet 2007;370:1432–1442.
227.Collaborative Group for the Study of Stroke in Young Women: Oral contraception and increased risk of cerebral ischemia or thrombosis. N Engl J Med 1973;288:871–878.
228.Handin, R: Thromboembolic complications of pregnancy and oral contraceptives. Prog Cardiovasc Dis 1974;16:395–405.
229.Layde, P, Beral, V, Kay, C: Further analyses of mortality in oral contraceptive users. Lancet 1981;1:541–546.
230.Bushnell, CD: Stroke and the female brain. Nat Clin Pract Neurol 2008;4:22–33.
231.Lidegaard, O, Kreiner, S: Cerebral thrombosis and oral contraceptives: A case-control study. Contraception 1998;57:303–314.
232.Schwartz, SM, Siscovick, DS, Longstreth, WT Jr, et al: Use of low-dose oral contraceptives and stroke in young women. Ann Intern Med 1997;127:596–603.
233.Schwartz, SM, Petitti, DB, Siscovick, DS, et al: Stroke and use of low-dose oral contraceptives in young women. A pooled analysis of two US studies. Stroke 1998;29:2277–2284.
234.Siritho, S, Thrift, A, McNeil, JJ, et al: Risk of ischemic stroke among users of the oral contracveptive pill. The Melbourne Risk Factor Study (MERFS) Group. Stroke 2003;34:1575–1580.
235.Jick, SS, Jick, H: The contraceptive patch in relation to ischemic stroke and acute myocardial infarction. Pharmacotherapy 2007;27:218–220.
236.Chasan-Taber, L, Stampfer, MJ: Epidemiology of oral contraceptives and cardiovascular disease. Ann Intern Med 1998;128:467–477.
237.Martinelli, I, Sacchi, E, Landi, G, et al: High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med 1998;338:1793–1797.
238.Lidegaard, O, Lokkegaard, E, Jensen, A, Skovlund, CW, Keiding, N: Thrombotic stroke and myocardial infarction with hormonal contraception. N Engl J Med 2012;366:2257–2266.
239.Qureshi, A, Giles, WH, Croft, JB, Stern, BJ: Number of pregnancies and risk for stroke and stroke subtypes. Arch Neurol 1997;54:203–206.
240.Kittner, SJ, Stern, BJ, Feeser, BR, et al: Pregnancy and the risk of stroke. N Engl J Med 1996;335:768–774.
241.Finucane, FF, Madans, JH, Bush, TL, et al: Decreased risk of stroke among postmenopausal hormone users. Arch Intern Med 1993;153:73–79.
242.Grodstein, F, Manson, JE, Colditz, GA, et al: A prospective observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med 2000;133:933–941.
243.Lokkegaard, E, Jovanovic, Z, Heitemann, BL, et al: Increased risk of stroke in hypertensive women using hormone therapy. Analysis based on the Danish Nurse Study. Arch Neurol 2003;60:1379–1384.
244.Wilson, PW, Garrison, RJ, Castelli, WP: Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study. N Engl J Med 1985;313:1038–1043.
245.Simon, JA, Hsia, J, Cawley, JA, et al: Postmenopausal hormone therapy and risk of stroke. The Heart and Estrogen/Progestin Replacement Study (HERS). Circulation 2001;103:638–642.
246.Grady, D, Harrington, D, Bittner, V, et al: For the HERS Research Group. Cardiovascular disease outcomes during 6–8 years of hormone therapy. The Heart and Estrogen/Progestin Replacement Study (HERS II). JAMA 2002;288:49–57.
247.Viscoli, CM, Brass, LM, Kernan, WN, et al: A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med 2001;345:1243–1249.
248.Rossouw, JE, Anderson, GL, Prentice, RL, et al: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002;288:321–333.
249.Wassertheil-Smoller, S, Hendrix, SL, Mimacher, M, et al: Effect of estrogen plus progestins on stroke in postmenopausal women. The Women’s Health Initiative: A randomized controlled trial. JAMA 2003;289:2673–2684.
250.The Women’s Health Initiative Steering Committee: Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. The Women’s Health Initiative: A randomized controlled trial. JAMA 2004;291:1701–1712.
251.Nelson, H, Walker, M, Zakher, B, Mitchell, J: Menopausal hormone therapy for the primary prevention of chronic conditions: a systematic review to update the US Preventive Serices Task Force recommendations. Ann Intern Med 2012; 157: 104–113.
252.Whitmer, RA, Quesenberry, CP, Zhou, J, Yaffe, K: Timing of hormone therapy and dementia: the critical window theory revisted. Ann Neurol 2011;69:163–169.
253.The 2012 Hormone Therapy Position Statement of the North American Menopause Society. Menopause 2012;19:257–271.
254.Moyer, VA, on behalf of the US Preventive Services Task Force: Menopausal hormone therapy for the primary prevention of chronic conditions: US Preventive Services Task Force recommendation statement. Ann Intern Med 2013;158:47–54.
255.Espeland, MA, Shumaker, SA, Leng, I, et al: Long-term effects on cognitive function of postmenopausal hormone therapy presecribed to women aged 50 to 55 years. JAMA Intern Med 2013;173:1429–1236.
256.Wannamethee, G, Shaper, AG: Physical activity and stroke in middle-aged men. BMJ 1992;304:597–601.
257.Sacco, RL, Gan, R, Boden-Albala, B, et al: Leisure-time physical activity and ischemic stroke risk. The Northern Manhattan Stroke Study. Stroke 1998;29:380–387.
258.Lindenstrom, E, Boysen, G, Nyboe, J: Lifestyle factors and risk of cerebrovascular disease in women. The Copenhagen City Heart Study. Stroke 1993;24:1468–1472.
259.Agnarsson, U, Thorgeirsson, G, Sigvaldson, H, Sigfusson, N: Effects of leisure-time physical activity and ventilatory function on risk for stroke in men: The Reykjavik Study. Ann Intern Med 1999;130:987–990.
260.Choi-Kwon, S, Kim, JS: Lifestyle factors and risk of stroke in Seoul, South Korea. J Stroke Cerebrovasc Dis 1998;7:414–420.
261.Lee, I-M, Paffenbarger, RS Jr: Physical activity and stroke incidence. The Harvard Alumni Health Study. Stroke 1998;29:2049–2054.
262.Lee, I-M, Hennekens, CH, Berger, K, et al: Exercise and risk of stroke in male physicians. Stroke 1999;30:1–6.
263.Hu, FB, Stampfer, MJ, Colditz, G, et al: Physical activity and risk of stroke in women. JAMA 2000;283:2961–2967.
264.Lee, CD, Folsom, AR, Blair, SN: Physical activity and stroke risk. A meta-analysis. Stroke 2003;34:2475–2482.
265.Paffenbarger, RS Jr, Wing, AL, Hyde, RT, Jung, DL: Physical activity and incidence of hypertension in college alumni. Am J Epidemiol 1983;117:245–257.
266.Paffenbarger, RS Jr, Jung, DL, Leung, RW, Hyde, RT: Physical activity and hypertension: An epidemiological view. Ann Med 1991;23:319–327.
267.Hayashi, T, Tsumura, K, Suematsu, C, et al: Walking to work and the risk of hypertension in men: The Osaka Health Survey. Ann Intern Med 1999;130:21–26.
268.Endres, M, Gertz, K, Lindauer, U, et al: Mechanisms of stroke protection by physical activity. Ann Neurol 2003;54:582–590.
269.Eckel, RH, Jakicic, JM, Ard, JD, et al: 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk. Circulation 2014;129:S76–S99.
270.Wing, S, Casper, M, Davis, WB, et al: Stroke mortality maps. Stroke 1988;19:1507–1513.
271.Lanska, DJ: Geographic distribution of stroke mortality in the United States: 1939–1941 to 1979–1981. Neurology 1993;43:1839–1851.
272.Lanska, DJ, Kryscio, R: Geographic distribution of hospitalization rates, case fatality, and mortality from stroke in the United States. Neurology 1994;44:1541–1550.
273.Glymour, WM, Avendano, M, Berkman, LF: Is the “stroke belt” worn from childhood? Risk of first stroke and state of residence in childhood and adulthood. Stroke 2007;38:2415–2421.
274.Howard, G, Prineas, R, Moy, C, et al: Racial and geographic differences in awareness, treatment, and control of hypertension: The Reasons for Geographic and Racial Differences in Stroke Study. Stroke 2006;37:1171–1178.
275.Vermeer, SE, Koudstaal, PJ, Oudkerk, M, et al: Prevalence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke 2002;33:21–25.
276.Howard, G, Safford, MM, Meschia, JF, et al. Stroke symptoms in individuals reporting no prior stroke or transient ischemic attack are associated with decreased indices of mental and physical functioning. Stroke 2007; 38: 2446–2452.
277.Caplan, LR: Significance of unexpected (silent) brain infarcts. In Caplan, LR, Shifrin, EG, Nicolaides, AN, Moore, WS (eds): Cerebrovascular Ischaemia. Investigation and Management. London: Med-Orion, 1996, pp 423–433.
278.Wardlaw, JM, Smith, EE, Biessels, GJ, et al: Neuroimaging standards for research into small vessel disease and its contribution to aging and neurodegeneration. Lancet Neurol 2013;12:822–838.
279.Ward, NS, Brown, MM: Leukoaraiosis. In Donnan, G, Norrving, B, Bamford, J, Bogousslavsky, J (eds):Subcortical Stroke, 2nd ed. Oxford: Oxford University Press, 2002, pp 47–66.
280.Caplan, LR, Schoene, WC: Clinical features of subcortical arteriosclerotic encephalopathy (Binswanger’s disease). Neurology 1978;28:1206–1215.
281.Caplan, LR: Binswanger’s disease – revisited. Neurology 1995;45:626–633.
282.Babikian, V, Ropper, AH: Binswanger disease: A review. Stroke 1987;18:1–12.
283.Fisher, CM: Binswanger’s encephalopathy: A review. J Neurol 1989;236:65–79.
284.Gray, F, Dubas, F, Roullet, E, Escourolle, R: Leukoencephalopathy in diffuse hemorrhagic cerebral amyloid angiopathy. Ann Neurol 1985;18:54–59.
285.Dubas, F, Gray, F, Roullet, E, Escourolle, R: Leukoencephalopathies arteriopathiques. Rev Neurol 1985;141:93–108.
286.Loes, D, Biller, J, Yuh, WT, et al: Leukoencephalopathy in cerebral amyloid angiopathy: MR imaging in four cases. AJNR Am J Neuroradiol 1990;11:485–488.
287.Baudrimont, M, Dubas, F, Joutel, A, et al: Autosomal dominant leukoencephalopathy and subcortical ischemic stroke: A clinicopathological study. Stroke 1993;24:122–125.
288.Davous, P: CADASIL: A review with proposed diagnostic criteria. Eur J Neurology 1998;5:219–233.
289.Chabriat, H, Levy, C, Taillia, H, et al: Patterns of MRI lesions in CADACIL. Neurology 1998;51:452–457.
290.Chen, YW, Gurol, ME, Rosand, J, et al: Progression of white matter lesions and hemorrhages in cerebral amyloid angiopathy. Neurology 2006;67:83–87.
291.Imaizumi, T, Honma, T, Horita, Y, et al: Hematoma size in deep intracerebral hemorrhage and its correlation with dot-like hemosiderin spots on gradient echo T2*-weighted MRI. J Neuroimaging 2006;16:236–242.
292.Imaizumi, T, Horita, Y, Hashimoto, Y, Niwa, J: Dotlike hemosiderin spots on T2*-weighted magnetic resonance imaging as a predictor of stroke recurrence: A prospective study. J Neurosurg 2004;101:915–920.
293.Klein, I, Iung, B, Labreuche, J, et al. and the IMAGE Study Group: Cerebral microbleeds are frequent in infective endocarditis. Stroke 2009;40:3461–3465.
294.Hollenhorst, R: Ocular manifestations of insufficiency or thrombosis of the internal carotid artery. Am J Ophthalmol 1959;47:753–767.
295.Fisher, CM: Observations of the fundus oculi in transient monocular blindness. Neurology 1959;9:333–347.
296.Kearns, T, Hollenhorst, R: Venous stasis retinopathy of occlusive disease of the carotid artery. Mayo Clin Proc 1963;38:304–312.
297.Carter, JE: Chronic ocular ischemia and carotid vascular disease. In Bernstein, EF (ed): Amaurosis Fugax. New York: Springer, 1988, pp 118–134.
298.Slaoui, T, Klein, IF, Guidoux, C, et al: Prevalence of subdiaphragmatic visceral infarction in cardioembolic stroke. Neurology 2010;74:1030–1032.
299.Chatzikonstantinou, A, Krissak, R, Fluchter, S, et al: CT angiography of the aorta is superior to transesophageal echocardiography for determining stroke subtypes in patients with cryptogenic ischemic stroke. Cerebrovasc Dis 2012;33:322–328.
300.Nicolaides, AN: Asymptomatic carotid stenosis and the risk of stroke (the ACSRS Study): Identification of a high-risk group. In Caplan, LR, Shifrin, EG, Nicolaides, AN, Moore, WS (eds): Cerebrovascular Ischaemia: Investigation and Management. London: Med-Orion, 1996, pp 435–441.
301.Wityk, RJ, Chang, H-M, Rosengart, A, et al: Proximal extracranial vertebral artery disease in the New England Medical Center Posterior Circulation Registry. Arch Neurol 1998;55:470–478.
302.Caplan, LR: Posterior Circulation Disease: Clinical Findings, Diagnosis, and Management. Boston: Blackwell, 1996.
303.Toghi, H, Yamanouchi, H, Murakami, M, et al: Importance of the hematocrit as a risk factor in cerebral infarction. Stroke 1978;9:369–374.
304.Harrison, MJG, Pollock, S, Thomas, D, et al: Hematocrit, hypertension, and smoking in patients with transient ischemic attack and in age and sex matched controls. J Neurol Neurosurg Psychiatry 1982;45:550–551.
305.Di Mascio, R, Marchioli, R, Vitullo, F, Tognoni, G: A positive relation between high hemoglobin values and the risk of ischemic stroke. Progetto 3 A Investigators. Eur Neurol 1996;36:85–88.
306.Harrison, MJG, Pollock, S, Kendall, B, et al: Effect of hematocrit on carotid stenosis and cerebral infarction. Lancet 1981;2:114–115.
307.Thomas, DJ, Marshall, J, Ross-Russel, RW, et al: Effects of hematocrit on cerebral blood flow in man. Lancet 1977;2:940–943.
308.Elkind, MS, Sciacca, RR, Boden-Albala, B, et al: Relative elevation in baseline leukocyte count predicts first cerebral infarction. Neurology 2005;64:2121–2125.
309.Mercuri, M, Bond, MG, Evans, G, et al: Leukocyte count and carotid atherosclerosis. Stroke 1991:22:134.
310.Elkind, MS, Cheng, I, Boden-Albala, B, et al: Elevated white blood cell count and carotid plaque thickness: The Northern Manhattan Stroke Study. Stroke 2001;32:842–849.
311.Elkind, MS, Sciacca, R, Boden-Albala, B, et al: Leukocyte count is associated with aortic arch plaque thickness. Stroke 2002;33:2587–2592.
312.Ovbiagele, B, Lynn, MJ, Saver, JL, et al: Leukocyte count and vascular risk in symptomatic intracranial atherosclerosis. WASID Study Group. Cerebrovasc Dis 2007;24:283–288.
313.Elkind, MS, Sciacca, RR, Boden-Albala, B, et al: Leukocyte count is associated with reduced endothelial reactivity. Atherosclerosis 2005;181:329–338.
314.Elkind, MS: Inflammation, atherosclerosis, and stroke. Neurologist 2006;12:140–148.
315.Elkind, MSV: Impact of innate inflammation in population studies. Ann NY Acad Sci 2010;1207:97–106.
316.Eikelboom, JW, Hankey, GJ, Baker, RI, et al: C-reactive protein in ischemic stroke and its etiologic subtypes. J Stroke Cerebrovasc Dis 2003;12:74–81.
317.Arenillas, JF, Alvarez-Sabin, J, Molina, CA, et al: C-reactive protein predicts further ischemic events in first-ever transient ischemic attack or stroke patients with intracranial large-artery occlusive disease. Stroke 2003;34:2463–2470.
318.Wakugawa, Y, Kiyohara, Y, Tanizaki, Y, et al: C-reactive protein and risk of first-ever ischemic and hemorrhagic stroke in general Japanese population. The Hisayama Study. Stroke 2006;37:27–32.
319.Gorelick, PB: Lipoprotein-associated phospholipase A2 and risk of stroke. Am J Cardiol 2008;101(suppl):34F–40F.
320.Wilhelmsen, L, Svarrdsudd, K, Korsan-Bengtsen, K, et al: Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984;311:501–505.
321.Drouet, L: Fibrinogen: A treatable risk factor. Cerebrovasc Dis 1996;6(suppl 1):2–6.
322.Kristensen, B, Malm, J, Nilsson, T, et al: Increased fibrinogen levels and acquired hypofibrinolysis in young adults with ischemic stroke. Stroke 1998;29:2261–2267.
323.Grotta, J, Ackerman, R, Correia, J, et al: Whole-blood viscosity parameters and cerebral blood flow. Stroke 1982;13:296–298.
324.Graham, IM, Daly, LE, Refsum, HM, et al: Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997;277:1775–1781.
325.Welch, GN, Loscalzo, J: Homocysteine and atherothrombosis. N Engl J Med 1998;338:1042–1050.
326.Giles, WH, Croft, JB, Greenlund, KJ, et al: Total homocyst(e)ine concentration and the likelihood of nonfatal stroke. Results from the Third National Health and Nutrition Examination Survey, 1988–1994. Stroke 1998;29:2473–2477.
327.Sacco, RL, Ananad, K, Lee, H-S, et al: Homocysteine and the risk of ischemic stroke in a triethnic cohort. The Northern Manhattan Study. Stroke 2004;35:2263–2269.
328.Selhub, J, Jacques, PF, Bostom, AG, et al: Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 1995;332:286–291.
329.Eikelboom, JW, Hankey, GJ, Ananad, S, et al: Association between high homocyst(e)ine and ischemic stroke due to large and small-artery disease but not other etiologic subtypes of ischemic stroke. Stroke 2000;31:1069–1075.
330.Toole, JF, Malinow, MR, Chambless, LE, et al: Lowering homocysteine in patients with ischemic stroke to reduce recurrent stroke, myocardial infarction and death. The Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial JAMA 2004;291:565–575.
331.VITATOPS Trial Study Group. B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: A randomised, double-blind, parallel, placebo-controlled trial. Lancet Neurol 2010;9:855–865.
332.Beamer, NB, Coull, BM, Clark, WM, Wynn, M: Microalbuminuria in ischemic stroke. Arch Neurol 1999;56:699–702.
333.Gaede, P, Vedel, P, Parving, H-H, Pederson, O: Intensified multifactorial intervention in patients with type 2 diabetes mellitus and micro-albuminuria: The Steno type 2 randomized study. Lancet 1999;353:617–622.
334.Gerstein, H, Mann, JFE, Yi, Q, et al: F Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. HOPE Study Investigators. JAMA 2001;286:421–426.
335.Ovbiagele, B: Impairment in glomerular filtration rate or glomerular filtration barrier and occurrence of stroke. Arch Neurol 2008;65:934–938.
336.Khatri, M, Wright, CB, Nickolas, TL, et al: Chronic kidney disease is associated with white matter hyperintensity volume. The Northern Manhattan Study (NOMAS). Stroke 2007;38:3121–3126.
337.Alberts, MJ: Genetics of Cerebrovascular Disease. Armonk, NY: Futura, 1999.
338.Meschia, JF, Worrall, BB: New advances in identifying genetic anomalies in stroke-prone probands. Curr Neurol Neurosci Rep 2004;4:420–426.
339.Gretarsdottir, S, Thorleifsson, G, Reynisdottir, ST, et al: The gene encoding phosphodiesterase 4D confers risk of ischemic stroke. Nat Genet 2003;35:131–138.
340.Yee, RYL, Brophy, VH, Cheng, S, et al: Polymorphisms of the phosphodiesterase 4D, camp-specific (PDE4D) gene and risk of ischemic stroke. A prospective, nested case-control evaluation. Stroke 2006;37:2012–2017.
341.Worrall, BB, Mychaleckyj, JC: PDE4D and stroke. A real advance or a case of the emperor’s new clothes? Stroke 2006;37:1955–1957.
342.Ruigrok, YM, Rinkel, GJE, Wijmenga, C: Genetics of intracranial aneurysms. Lancet Neurol 2005;4:179–189.
343.Ruigrok, YM, Rinkel, GJ, Wijmenga, C: The versican gene and the risk of intracranial aneurysms. Stroke 2006;37:2372–2374.
345.Wolf, PA, D’Agostino, RB, Belanger, AJ, Kannel, WB: Probability of stroke: A risk profile from the Framingham Study. Stroke 1991;22:312–318.
346.Wolf, PA, Belanger, AJ, D’Agostino, RB: Quantifying stroke risk factors and potentials for risk reduction. Cerebrovasc Dis 1993;3(suppl 1):7–14.
347.Goff, DC, Lloyd-Jones, DM, Bennet, G, et al: 2013 ACC/AHA guideline on the assessment of cardiovascular risk: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014;63:2935–2959.
348.Stone, NJ, Robinson, JG, Lichtenstein, AH, et al: 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014;63:2889–2934.
349.James, PA, Oparil, S, Carter, BL, et al: 2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eight Joint National Committee (JNC 8). JAMA 2014;311:507–520, erratum 7;311:1809.
350.Banach, M, Aronow, WS: Blood pressure J-curve: Current concepts. Curr Hypertens Rep 2012;14:556–566.
351.Meschia, JF, Bushnell, C, Bodsen-Albala, B, et al. on behalf of the American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, Council on Functional Genomics and Translational Biology, and Council on Hypertension: Guidelines for the primary prevention of stroke. A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014;45:3754–3832.
352.Yamamoto, H, Bogousslavsky, J: Mechanisms of second and further strokes. J Neurol Neurosurg Psychiatry 1998;64:771–776.
353.Caplan, LR: Editorial. J Neurol Neurosurg Psychiatry 1998;64:716.
354.Inzitari, D, Eliasziw, M, Gates, P, et al: The causes and risk of stroke in patients with asymptomatic internal-carotid-artery stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 2000;342:1693–1700.
355.Leonberg, SC, Elliot, FA: Prevention of recurrent stroke. Stroke 1981;12:731–735.
356.Ovbiagele, B, Saver, JL, Fredieu, A, et al: In-hospital initiation of secondary stroke prevention therapies yields high rates of adherence at follow-up. Stroke 2004;35:2879–2883.
357.Touze, E, Coste, J, Voicu, M, et al: Importance of in-hospital initiation of therapies and therapeutic inertia in secondary stroke prevention. Implemetation of prevention after a cerebrovascular event (IMPACT) study. Stroke 2008;39:1834–1843.